The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research
Open Access
- 12 February 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Briefings in Functional Genomics and Proteomics
- Vol. 7 (1) , 35-49
Abstract
Toxicoproteomics uses the discovery potential of proteomics in toxicology research by applying global protein measurement technologies to biofluids and tissues after host exposure to injurious agents. Toxicoproteomic studies thus far have focused on protein profiling of major organs and biofluids such as liver and blood in preclinical species exposed to model toxicants. The slow pace of discovery for new biomarkers, toxicity signatures and mechanistic insights is partially due to the limited proteome coverage derived from analysis of native organs, tissues and body fluids by traditional proteomic platforms. Improved toxicoproteomic analysis would result by combining higher data density LC-MS/MS platforms with stable isotope labelled peptides and parallel use of complementary platforms. Study designs that remove abundant proteins from biofluids, enrich subcellular structures and include cell specific isolation from heterogeneous tissues would greatly increase differential expression capabilities. By leveraging resources from immunology, cell biology and nutrition research communities, toxicoproteomics could make particular contributions in three inter-related areas to advance mechanistic insights and biomarker development: the plasma proteome and circulating microparticles, the adductome and idiosyncratic toxicity.Keywords
This publication has 103 references indexed in Scilit:
- Mapping the human plasma proteome by SCX-LC-IMS-MSJournal of the American Society for Mass Spectrometry, 2007
- Protein Targets of Reactive Electrophiles in Human Liver MicrosomesChemical Research in Toxicology, 2007
- Idiosyncratic Adverse Reactions to Antiepileptic DrugsEpilepsia, 2007
- The reactive metabolite target protein database (TPDB) – a web-accessible resourceBMC Bioinformatics, 2007
- The combination of nuclear and mitochondrial mutations as a risk factor for idiosyncratic toxicityBritish Journal of Clinical Pharmacology, 2007
- Alterations in the Rat Serum Proteome during Liver Injury from Acetaminophen ExposureThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failureKidney International, 2006
- Computational Proteomics Analysis System (CPAS): An Extensible, Open-Source Analytic System for Evaluating and Publishing Proteomic Data and High Throughput Biological ExperimentsJournal of Proteome Research, 2005
- Scoring proteomes with proteotypic peptide probesNature Reviews Molecular Cell Biology, 2005
- Systems Biology and New Technologies Enable Predictive and Preventative MedicineScience, 2004